Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ariana C Acevedo-Diaz"'
Autor:
Carolina J. García García, Ariana C. Acevedo Diaz, Neeraj Kumari, Suman Govindaraju, Marimar de la Cruz Bonilla, F. Anthony San Lucas, Nicholas D. Nguyen, Iancarlos Jiménez Sacarello, Helen Piwnica-Worms, Anirban Maitra, Cullen M. Taniguchi
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Radiation therapy for abdominal tumors is challenging because the small intestine is exquisitely radiosensitive. Unfortunately, there are no FDA-approved therapies to prevent or mitigate GI radiotoxicity. The EGLN protein family are oxygen sensors th
Externí odkaz:
https://doaj.org/article/05fcc8c992f74d3c958d1640320a0cbb
Autor:
Nicholas D. Nguyen, Meifang Yu, Vinit Y. Reddy, Ariana C. Acevedo-Diaz, Enzo C. Mesarick, Joseph Abi Jaoude, Min Yuan, John M. Asara, Cullen M. Taniguchi
Publikováno v:
Metabolites, Vol 11, Iss 9, p 627 (2021)
Mitochondria are dynamic organelles that constantly alter their shape through the recruitment of specialized proteins, like mitofusin-2 (Mfn2) and dynamin-related protein 1 (Drp1). Mfn2 induces the fusion of nearby mitochondria, while Drp1 mediates m
Externí odkaz:
https://doaj.org/article/1e717f76abe7404f91e3076317568b43
Autor:
Ariana C Acevedo-Diaz, Gabriela Ortiz-Soto, Ivette J. Suarez-Arroyo, Michelle M. Martínez Montemayor, Astrid Zayas-Santiago
Publikováno v:
Nutrients
Nutrients, Vol 11, Iss 5, p 1116 (2019)
Nutrients, Vol 11, Iss 5, p 1116 (2019)
Breast cancer (BC) is the second leading cause of cancer death among women worldwide. The main cause of BC morbidity and mortality is the invasiveness capacity of cancer cells that may lead to metastasis. Here, we aimed to investigate the therapeutic
Autor:
Ariana C. Acevedo Diaz, Jael Reyes Chea, Michelle M. Martínez-Montemayor, Ivette J. Suarez-Arroyo
Publikováno v:
Cancer Research. 80:3678-3678
Breast cancer (BC) affects approximately 1 in 8 women and is the second leading cause of cancer among women in the United States. BC tumors frequently overexpress Epidermal Growth Factor Receptor (EGFR) which contributes to BC progression and poor cl